The Modern Financial Data Platform

Subscribe for $2

Shionogi & Co Stock 4507.T

Price

2,647.00
Today +/-
+0.23
Today %
+1.52 %

Shionogi & Co stock price

Loading chart...
Weekly
Details

Price

ⓘ

Overview

The Quote Chart provides detailed and dynamic insights into the Shionogi & Co stock's performance, showcasing daily, weekly, or monthly aggregated quotes. Users can switch between different time frames to analyze the stock's progression meticulously and make informed investment decisions.

Intraday Feature

The intraday feature provides real-time data, allowing investors to view the Shionogi & Co stock’s price fluctuations within the trading day, facilitating timely and strategic investment decisions.

Total Return and Relative Price Change

View the total return of the Shionogi & Co stock to gauge its profitability over time. The relative price change, based on the first quote available in the selected timeframe, offers insights into the stock’s performance, assisting in evaluating its investment potential.

Interpretation and Investment

Utilize the comprehensive data presented in the Quote Chart to analyze Shionogi & Co's market trends, price movements, and potential returns. Make informed investment choices by comparing different time frames and evaluating intraday data for optimized portfolio management.

Shionogi & Co Stock Price History

DateShionogi & Co Price
11/10/20252,647.00 undefined
11/7/20252,607.00 undefined
11/6/20252,624.00 undefined
11/5/20252,594.50 undefined
11/4/20252,581.00 undefined
10/31/20252,580.00 undefined
10/30/20252,483.50 undefined
10/29/20252,487.00 undefined
10/28/20252,494.00 undefined
10/27/20252,483.00 undefined
10/24/20252,443.00 undefined
10/23/20252,451.00 undefined
10/22/20252,450.00 undefined
10/21/20252,454.50 undefined
10/20/20252,445.50 undefined
10/17/20252,399.00 undefined
10/16/20252,416.00 undefined
10/15/20252,418.00 undefined
10/14/20252,420.00 undefined

Shionogi & Co Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Shionogi & Co, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Shionogi & Co from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Shionogi & Co’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Shionogi & Co. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Shionogi & Co’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Shionogi & Co’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Shionogi & Co’s growth potential.

Shionogi & Co Revenue, EBIT and net profit per share

DateShionogi & Co RevenueShionogi & Co EBITShionogi & Co Net Income
2028e578.94 B undefined0 undefined202.5 B undefined
2027e567.37 B undefined0 undefined197.4 B undefined
2026e506.87 B undefined136.11 T undefined183.02 B undefined
2025438.27 B undefined159.32 B undefined170.44 B undefined
2024435.08 B undefined168.38 B undefined162.03 B undefined
2023426.68 B undefined159.25 B undefined184.97 B undefined
2022335.14 B undefined110.67 B undefined114.19 B undefined
2021297.18 B undefined118.72 B undefined111.86 B undefined
2020333.37 B undefined128.71 B undefined122.19 B undefined
2019367.96 B undefined163.6 B undefined137.19 B undefined
2018344.67 B undefined115.22 B undefined108.87 B undefined
2017338.89 B undefined108.18 B undefined83.88 B undefined
2016309.97 B undefined91.41 B undefined66.69 B undefined
2015273.99 B undefined50.37 B undefined44.06 B undefined
2014289.72 B undefined63.56 B undefined41.83 B undefined
2013282.9 B undefined58.85 B undefined66.73 B undefined
2012267.28 B undefined47 B undefined27.1 B undefined
2011282.35 B undefined46.89 B undefined20.03 B undefined
2010278.5 B undefined52.44 B undefined38.63 B undefined
2009227.51 B undefined31.93 B undefined15.66 B undefined
2008214.27 B undefined40.4 B undefined25.06 B undefined
2007199.76 B undefined28.86 B undefined18.59 B undefined
2006196.39 B undefined29.23 B undefined22.67 B undefined

Shionogi & Co Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (B)
REVENUE GROWTH (%)
GROSS MARGIN (%)
GROSS INCOME (B)
NET INCOME (B)
NET INCOME GROWTH (%)
DIV. ()
DIV. GROWTH (%)
SHARES (M)
DOCUMENTS
199419951996199719981999200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023202420252026e2027e2028e
344.55365.31359.48370.12348.75372.17400.28412.66420.19285.23200.49199.36196.39199.76214.27227.51278.5282.35267.28282.9289.72273.99309.97338.89344.67367.96333.37297.18335.14426.68435.08438.27506.87567.37578.94
-6.03-1.602.96-5.776.727.553.091.82-32.12-29.71-0.56-1.491.727.266.1822.411.38-5.345.852.41-5.4313.139.331.706.76-9.40-10.8612.7727.321.970.7315.6511.932.04
40.8439.1838.4338.3938.8237.5436.7436.1234.8646.2260.1762.8565.0166.1967.9968.7972.6271.0570.9172.2373.0870.0075.8877.0578.5684.8982.9782.3383.4785.4186.7685.4473.8766.0064.68
140.73143.12138.16142.11135.38139.72147.08149.04146.5131.83120.63125.3127.68132.22145.67156.49202.24200.61189.52204.33211.72191.8235.22261.11270.76312.37276.59244.65279.72364.44377.48374.44000
11.0911.7311.8413.369.579.8112.8712.618.465.82.118.8622.6718.5925.0615.6638.6320.0327.166.7341.8344.0666.6983.88108.87137.19122.19111.86114.19184.97162.03170.44183.02197.4202.5
-5.840.8712.92-28.392.4831.21-1.97-32.96-31.42-63.84799.3320.22-17.9934.79-37.51146.63-48.1535.33146.22-37.315.3351.3525.7829.7926.02-10.93-8.462.0861.99-12.405.197.387.862.59
------------10.005.336.008.6710.6712.6713.3313.3314.6716.0018.6722.6725.3329.3333.3335.3336.6740.0050.0056.6766.0047.9250.04
0000000000000-46.712.5744.523.0718.745.21010.059.0716.6921.4211.7315.7913.6463.799.082513.3416.46-27.394.42
351351357358356351347348348348346345341341338335335335335335335333.66330.57327.77322.6315.58309.13306.55904.75893.42870.64850.94000
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Details

Keystats

ⓘ

Revenue and Growth

The Shionogi & Co Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the Shionogi & Co is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETS
CASH BALANCE (B)
RECEIVABLES (B)
OTHER REC. (B)
INVENTORIES (B)
OTHER CURRENT LIAB. (B)
CURRENT ASSETS (B)
TANGIBLE ASSETS (B)
LONG-T. INVEST. (B)
LONG-T. REC. (B)
INTANGIBLE ASSETS (B)
GOODWILL (B)
OTHER NON-CURRENT ASSETS (B)
NON-CURRENT ASSETS (B)
TOTAL ASSETS (T)
LIABILITIES
COMMON STOCK (B)
ADDITIONAL PAID-IN CAPITAL (B)
RETAINED EARNINGS (T)
OTHER EQUITY (B)
UNREAL. GAINS/LOSSES (B)
EQUITY (T)
LIABILITIES (B)
PROVISIONS (B)
OTHER SHORT-TERM LIAB. (B)
SHORT-TERM DEBTS (B)
LONG-TERM DEBT PORTION (B)
SHORT-TERM REC. (B)
LONG-T. LIAB. (B)
DEFERRED TAXES (B)
OTHER LIAB. (B)
LONG-T. LIABILITIES (B)
DEBT (B)
TOTAL CAPITAL (T)
19941995199619971998199920002001200220032004200520062007200820092010201120122013201420152016201720182019202020212022202320242025
                                                               
63.1581.21102.34117.53114.1796.14107.68117.9489.9679.8898.1105.490.6586.8574.1558.8104.21116.49104.98106.01114.34109.48177.43206.65264.41346.33380.02418.32465.18563.36573.85644.82
118.06130.46123.95125.95118.18134.89143.36143.55125.8476.3171.473.469.967.5667.5975.3779.469.4965.5567.964.2770.5665.1659.353.2100.4579.3577.18122.54109.31122.57120.34
00000000000000000000000000.90.651.030.470.530.260.21
66.7261.0759.8654.8457.3855.859.1659.1356.9241.2833.5529.727.1832.434.0843.0349.3447.3450.1249.3348.3744.4842.1841.3934.6435.1333.823845.8957.9264.9265.48
10.9814.768.995.165.5211.0716.617.1523.113.0111.113.5820.5922.0819.1425.5217.7123.6220.2843.6226.1635.4330.8436.0527.2610.8422.1921.725.1253.0822.6127.66
258.92287.5295.14303.47295.24297.91326.79337.76295.81210.49214.15222.06208.33208.89194.96202.72250.66256.93240.93266.85253.13259.95315.61343.38379.5493.65516.03556.24659.21784.19784.21858.5
63.2762.8361.4868.9868.8673.2786.6187.9786.3975.5871.9968.1964.2567.8170.3871.8162.4570.2274.2878.4778.9877.0278.6778.7975.9676.976.0195.71112.42118.57124.03134.81
18.7618.7118.0611.113.0919.2314.8360.4382.0573.180.7982.07129.04123.37105.4566.8171.8760.6563.57122.63149.52158.34147.02136.54156.25302.71204.66244.2269.15274.09320.09327.52
2.382.181.731.521.727.220000000000000000000000.160.050.0700
1.060.930.792.462.161.812.562.564.024.994.946.987.136.145.6248.7649.1940.7643.1230.1729.9529.0626.2849.9742.2147.851.7176.5681.2296.31117.62143.65
00000000.861.190.330.240.1600071.6369.8758.8363.5740.2942.8846.5341.2137.6332.853.367.859.369.649.8215.2915.75
9.398.478.339.259.999.7311.757.0111.217.224.0517.5318.9323.3637.2940.1136.7135.8436.6936.4730.353230.8423.9624.714.1217.4516.9318.9728.8255.6955.12
94.8793.1190.3993.395.82111.26115.75158.83184.86161.22162.01174.93219.35220.68218.74299.12290.09266.3281.23308.04331.67342.95324.03326.89331.96444.9357.67442.92491.45527.68632.71676.85
0.350.380.390.40.390.410.440.50.480.370.380.40.430.430.410.50.540.520.520.570.580.60.640.670.710.940.8711.151.311.421.54
                                                               
21.2821.2821.2821.2821.2821.2821.2821.2821.2821.2821.2821.2821.2821.2821.2821.2821.2821.2821.2821.2821.2821.2821.2821.2821.2821.2821.2821.2821.2821.2821.2821.28
20.2320.2320.2320.2320.2320.2320.2320.2320.2320.2320.2320.2320.2320.2320.2320.2320.2320.2320.2320.2320.2320.2320.2320.2320.2321.2821.0313.7314.4615.214.2417.85
0.160.170.170.180.190.20.210.220.230.230.230.250.270.280.30.30.330.340.350.410.430.460.50.510.570.610.710.750.830.941.071.12
0000000-2.63-1.48-1.56-1.59-1.54-0.16-0.08-0.18-25.19-23.3-37.37-38.95-24.72-12.7-1.66-13-25.17-14.27181.6291.85116.84164.83186.03271.78272.93
000000024.5312.065.0221.0219.9638.1234.2622.078.2110.363.737.7316.0625.2928.68025.0435.8600000271.780
0.20.210.220.230.230.240.260.290.280.280.290.310.350.350.360.330.360.350.360.440.490.520.530.550.640.840.840.91.031.161.641.43
65.1878.3272.8469.0263.9971.8379.2283.9882.112.1210.358.6610.2312.1911.315.4413.412.888.6110.739.6311.5711.0511.948.029.4410.769.916.3714.0114.8113.58
17.0117.5517.8417.3717.361010.1210.199.947.826.347.817.485.966.715.336.477.066.757.137.078.3210.129.188.740000000
17.1719.7518.3223.2619.0424.6527.5427.1929.5919.917.0432.6834.1729.3924.4332.0332.9545.8742.7141.3441.9747.8750.8169.4745.8182.486786.9105.08141.53116.23112.35
8.798.7111.5112.5310.0414.4417.2618.7218.947.721.030000100007.5000000000000
000019.57000000200001414142431.520000104.223.363.382.953.012.873.46
108.15124.34120.5122.18130120.92134.14140.08140.5747.5634.7769.1551.8847.5342.4476.866.8379.8282.0698.2178.6767.7671.9890.672.5796.1581.12100.18124.4158.55133.91129.39
22.5222.3521.9621.641.742022.0521.2121.0721.0120.18000091107936930.0310.0330.0930.0730.0518.496.014.794.613.736.48.7518.42
000000014.22.390.348.3411.623.2824.718.561415.446.627.7312.7612.6312.6312.869.3700.441.957.757.815.924.364.4
24.625.1425.2525.425.0525.2528.7632.235.5127.820.4916.1815.0911.5810.469.969.5215.716.1710.2611.0611.5910.8514.0415.5722.8520.6321.9121.3819.0617.3420.64
47.1247.4947.2147.0426.7845.2550.8167.658.9849.1449.0127.7838.3736.2829.02114.95131.95115.3292.953.0433.7254.3153.7853.4734.0629.327.3734.2632.9231.3730.4543.46
155.26171.83167.71169.23156.78166.17184.95207.67199.5596.783.7796.9390.2483.8171.46191.76198.78195.14174.96151.25112.39122.07125.76144.06106.62125.45108.49134.44157.32189.92164.36172.85
0.350.380.380.390.390.410.440.490.480.370.380.410.440.440.430.520.560.540.540.590.60.650.660.690.740.960.951.041.191.351.811.6
Details

Balance Sheet

ⓘ

Understanding the Balance Sheet

The balance sheet of Shionogi & Co provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand Shionogi & Co's financial health and stability.

Assets

Shionogi & Co's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that Shionogi & Co must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of Shionogi & Co after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into Shionogi & Co's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (B)
DEPRECIATION (B)
DEFERRED TAXES (M)
CHANGES IN WORKING CAPITAL (B)
NON-CASH ITEM (B)
PAID INTEREST (B)
PAID TAXES (B)
NET CASH FLOW FROM OPERATING ACTIVITIES (B)
CAPITAL EXPENDITURES (M)
CASH FLOW FROM INVESTING ACTIVITIES (B)
CASH FLOW FROM OTHER INVESTING ACTIVITIES (B)
INTEREST INCOME AND EXPENSES (M)
NET DEBT CHANGE (B)
NET CHANGE IN EQUITY (M)
CASH FLOW FROM FINANCING ACTIVITIES (B)
CASH FLOW FROM OTHER FINANCING ACTIVITIES (B)
TOTAL DIVIDENDS PAID (M)
NET CHANGE IN CASH FLOW (B)
FREE CASH FLOW (M)
SHARE-BASED COMPENSATION (M)
200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023
27.724.5618.769.145.1831.6638.831.7239.9630.7958.5433.1441.4958.3164.8782.0597.45122.7137.38174.04158.52143.02126.27220.33
9.759.269.8110.199.79.418.658.810.6714.3721.7822.3619.7115.1215.6315.6515.8716.3419.0114.4314.1214.7816.3517.17
000000000000000000000000
-22.22-13.33-1.51-6.177.528.96-18.21-17.44-29.09-21.55-21.57-3.69-6.67-9.854.37-17.82-3.46-8.05-4.41-40.64-11.56-23.75-25.10.07
4.932.92-0.7-12.25-7.35-21.47-12.33-8.97-5.925.51-5.854.730.19-4.29-5.37-34.28-7.57-19.08-22.1917.17-29.13-25.01-15.46-59.7
0.650.660.650.520.460.420.230.060.050.781.511.491.231.080.910.310.190.210.5533.660.350.260.090.09
14.6616.7716.1210.994.522.2813.713.4211.5912.5313.7422.522.8919.73-9.4530.2625.4734.0438.6223.548.3532.2526.0427.28
20.1523.4126.360.915.0528.5616.9114.1115.6229.1252.956.5254.7359.2879.545.6102.29111.9129.79165131.94109.04102.07177.87
-9,355-8,331-8,809-9,012-4,404-5,424-5,386-11,410-11,660-11,200-13,156-11,878-29,239-21,285-17,396-13,379-15,100-23,259-17,012-25,395-11,768-32,944-31,564-37,187
-30.3313.2-51.026.04-8.049.79-12.05-8.42-5.34-149.05-0.83-13.94-38.29-19.96-20.04-31.7-32.89-31.64-51.24-56.26-29.14-5.26-96.2-48.29
-20.9821.53-42.2115.05-3.6415.21-6.662.996.33-137.8512.33-2.07-9.051.33-2.64-18.32-17.79-8.38-34.23-30.86-17.3827.68-64.64-11.11
000000000000000000000000
1.220.59-0.11-11.22-7.21-1.04-19.94-0.72-0.8114.255.96-14-14-23.98-390-0.0400-13.02-3.54-3.65-3.45-3.16
00000-7,231-176-337-10,204-371-80-10-2-4-14-30,050-25-35,014-29,369-50,270-50,159-16,600-14-49,539
-1.93-0.01-3.23-14.87-10.34-11.21-24.8-7.18-17.12105.3-4.98-27.01-27.75-37.69-53.8-46.21-18.53-57.41-53.89-89.91-88.17-43.89-36.62-84.12
-0.042.35-0.16-0.7-0.20-0-0-00.11-0.15-0.29-0.37-0.33-0.07-0.17-0.25-0.29-0.291.02-3.358.89-04.72
-3,116-2,945-2,954-2,953-2,936-2,935-4,675-6,122-6,114-8,701-10,701-12,707-13,375-13,377-14,718-16,060-18,216-22,112-24,235-27,639-31,122-32,529-33,146-36,142
-12.2436.95-27.55-8.22-2.8727.09-19.57-1.6-6.93-16.0746.1313.03-122.866.8-29.6249.0221.5823.0819.6613.0667.31-21.7554.8
10,79515,07817,546-8,11110,65023,13311,5252,7043,95917,91939,74444,64425,48637,99162,10032,22587,19088,644112,776139,605120,17276,09570,504140,679
000000000000000000000000

Shionogi & Co stock margins

The Shionogi & Co margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Shionogi & Co. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Shionogi & Co.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Shionogi & Co's sales revenue. A higher gross margin percentage indicates that the Shionogi & Co retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Shionogi & Co's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Shionogi & Co's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Shionogi & Co's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Shionogi & Co. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Shionogi & Co's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Shionogi & Co Margin History

Shionogi & Co Gross marginShionogi & Co Profit marginShionogi & Co EBIT marginShionogi & Co Profit margin
2028e85.44 %0 %34.98 %
2027e85.44 %0 %34.79 %
2026e85.44 %26,852.95 %36.11 %
202585.44 %36.35 %38.89 %
202486.76 %38.7 %37.24 %
202385.41 %37.32 %43.35 %
202283.47 %33.02 %34.07 %
202182.33 %39.95 %37.64 %
202082.97 %38.61 %36.65 %
201984.89 %44.46 %37.28 %
201878.56 %33.43 %31.59 %
201777.05 %31.92 %24.75 %
201675.88 %29.49 %21.51 %
201570 %18.38 %16.08 %
201473.08 %21.94 %14.44 %
201372.23 %20.8 %23.59 %
201270.91 %17.59 %10.14 %
201171.05 %16.61 %7.09 %
201072.62 %18.83 %13.87 %
200968.79 %14.03 %6.88 %
200867.99 %18.85 %11.7 %
200766.19 %14.45 %9.31 %
200665.01 %14.88 %11.54 %

Shionogi & Co Stock Sales Revenue, EBIT, Earnings per Share

The Shionogi & Co earnings per share therefore indicates how much revenue Shionogi & Co has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Shionogi & Co earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Shionogi & Co's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Shionogi & Co’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Shionogi & Co's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Shionogi & Co Revenue, EBIT and net profit per share

DateShionogi & Co Sales per ShareShionogi & Co EBIT per shareShionogi & Co Earnings per Share
2028e680.35 undefined0 undefined237.97 undefined
2027e666.75 undefined0 undefined231.98 undefined
2026e595.66 undefined159,953.04 undefined215.07 undefined
2025515.04 undefined187.23 undefined200.29 undefined
2024499.72 undefined193.39 undefined186.1 undefined
2023477.58 undefined178.24 undefined207.03 undefined
2022370.42 undefined122.32 undefined126.21 undefined
2021969.41 undefined387.29 undefined364.89 undefined
20201,078.42 undefined416.37 undefined395.28 undefined
20191,165.99 undefined518.41 undefined434.73 undefined
20181,068.42 undefined357.16 undefined337.47 undefined
20171,033.93 undefined330.04 undefined255.91 undefined
2016937.7 undefined276.51 undefined201.74 undefined
2015821.16 undefined150.95 undefined132.05 undefined
2014864.83 undefined189.72 undefined124.87 undefined
2013844.49 undefined175.67 undefined199.19 undefined
2012797.84 undefined140.31 undefined80.9 undefined
2011842.84 undefined139.98 undefined59.78 undefined
2010831.35 undefined156.53 undefined115.3 undefined
2009679.14 undefined95.3 undefined46.75 undefined
2008633.93 undefined119.52 undefined74.15 undefined
2007585.8 undefined84.65 undefined54.53 undefined
2006575.92 undefined85.71 undefined66.49 undefined

Shionogi & Co business model

The company Shionogi & Co Ltd is a Japanese pharmaceutical company based in Osaka. It was founded in 1878 and has since become a significant player in the industry. It currently employs over 6,000 employees worldwide and is listed on the Tokyo Stock Exchange. Shionogi is divided into several business segments that offer different products and services. The largest segment is the pharmaceutical division, which specializes in the development and marketing of drugs. The company has strong expertise in infectious diseases, pain management, and oncology, and operates in many countries worldwide. One flagship product is the antibiotic Cefditoren, used to treat various bacterial infections. In addition to the pharmaceutical division, Shionogi is also active in other areas. For example, the company offers diagnostic and laboratory services, operating multiple labs in Japan and other countries. Another business segment is the production and marketing of nutritional supplements, sold in Japan, China, and the USA. Shionogi's business model is based on extensive research and development, as well as strong brand positioning. The company invests a significant portion of its revenue each year in the research and development of new drugs and better treatment options for existing diseases. Thanks to the high quality of its products and strong brand, the company has a loyal customer base. In recent years, Shionogi has focused on international expansion opportunities and has expanded its activities in various regions. For example, it has partnered with US pharmaceutical company Purdue Pharma to develop and market a novel pain medication. Shionogi's annual revenue is around 1.5 billion euros. The company is particularly strong in Japan and other Asian countries, but is also active in the US and Europe. In the coming years, Shionogi aims to further expand its international business and solidify its position as a significant player in the industry. Key focuses will be on the launch of new products and finding treatments for previously incurable diseases. Overall, Shionogi is an innovative and successful company that utilizes its expertise in the pharmaceutical industry in various ways. With its dedicated employees and strong brand, it will continue to play an important role in the industry. Shionogi & Co is one of the most popular companies on Eulerpool.com.

Shionogi & Co SWOT Analysis

Helpful
Harmful
Internal

Strengths

[ { "heading": "1.", "text": "Strong" }, { "heading": "2.", "text": "Diverse" }, { "heading": "3.", "text": "Robust" }, { "heading": "4.", "text": "Well-established" }, { "heading": "5.", "text": "Effective" } ]

Weaknesses

[ { "heading": "1.", "text": "Vulnerability" }, { "heading": "2.", "text": "Limited" }, { "heading": "3.", "text": "High" }, { "heading": "4.", "text": "Potential" }, { "heading": "5.", "text": "Lack" } ]

External

Opportunities

[ { "heading": "1.", "text": "Expansion" }, { "heading": "2.", "text": "Collaboration" }, { "heading": "3.", "text": "Increasing" }, { "heading": "4.", "text": "Mergers" }, { "heading": "5.", "text": "Potential" } ]

Threats

[ { "heading": "1.", "text": "Intense" }, { "heading": "2.", "text": "Regulatory" }, { "heading": "3.", "text": "Economic" }, { "heading": "4.", "text": "Rapid" }, { "heading": "5.", "text": "Increasing" } ]

Eulerpool Premium

The World’s Best Investors Are On Eulerpool

Subscribe for $2

Shionogi & Co Eulerpool Fair Value

Details

Fair Value

ⓘ

Understanding Fair Value

The fair value of a stock provides insights into whether the stock is currently undervalued or overvalued. It is calculated based on profit, revenue, or dividends and offers a comprehensive perspective of the stock’s intrinsic value.

Income-Based Fair Value

This is calculated by multiplying the earnings per share by the average P/E ratio of the selected past years for smoothing. If the fair value is higher than the current market price, it suggests that the stock is undervalued.

Example 2022

Fair Value Profit 2022 = Earnings per Share 2022 / Average P/E Ratio 2019 - 2021 (3 Years Smoothing)

Revenue-Based Fair Value

It is derived by multiplying the revenue per share by the average price-to-sales ratio of the selected past years for smoothing. An undervalued stock is identified if the fair value exceeds the ongoing market price.

Example 2022

Fair Value Revenue 2022 = Revenue per Share 2022 / Average PSR 2019 - 2021 (3 Years Smoothing)

Dividend-Based Fair Value

This value is determined by dividing the dividend per share by the average dividend yield of the selected past years for smoothing. A higher fair value than the market price indicates an undervalued stock.

Example 2022

Fair Value Dividend 2022 = Dividend per Share 2022 * Average Dividend Yield 2019 - 2021 (3 Years Smoothing)

Expectations and Forecasts

Future expectations provide potential trajectories for stock prices and aid investors in decision-making. The expected values are forecasted figures of fair value, taking into account the growth or decline trends of profit, revenue, or dividend.

Comparative Analysis

Comparing the fair value based on profit, revenue, and dividend provides a holistic overview of the stock’s financial health. Observing the annual and per-annual variations contributes to understanding the consistency and reliability of stock performance.

Shionogi & Co historical P/E ratio, EBIT multiple, and P/S ratio

Eulerpool Premium

The World’s Best Investors Are On Eulerpool

Subscribe for $2

Shionogi & Co shares outstanding

The number of shares was Shionogi & Co in 2024 — This indicates how many shares 870.642 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Shionogi & Co earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Shionogi & Co's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Shionogi & Co’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Shionogi & Co's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Shionogi & Co stock splits

In Shionogi & Co's history, there have been no stock splits.

Shionogi & Co dividend history and estimates

In 2024, Shionogi & Co paid a dividend amounting to 50 undefined. Dividend means that Shionogi & Co distributes a portion of its profits to its owners.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Dividend
Dividend (Estimate)
Details
Details

Dividend

ⓘ

Dividend Overview

The dividend per year chart for Shionogi & Co provides a comprehensive view of the annual dividends distributed to shareholders. Analyze the trend to understand the consistency and growth in dividend payouts over the years.

Interpretation and Use

A consistent or increasing trend in dividends can indicate the company's profitability and financial health. Investors can use this data to identify Shionogi & Co’s potential for long-term investment and income generation through dividends.

Investment Strategy

Incorporate the dividend data in evaluating Shionogi & Co's overall performance. A thorough analysis, considering other financial aspects, will help in making informed investment decisions for optimal capital growth and income generation.

Shionogi & Co Dividend History

DateShionogi & Co Dividend
2028e50.04 undefined
2027e47.92 undefined
2007e2.67 undefined
202666 undefined
202556.67 undefined
202450 undefined
202340 undefined
202236.67 undefined
202135.33 undefined
202033.33 undefined
201929.33 undefined
201825.33 undefined
201722.67 undefined
201618.67 undefined
201516 undefined
201414.67 undefined
201313.33 undefined
201213.33 undefined
201112.67 undefined
201010.67 undefined
20098.67 undefined
20086 undefined
2007e2.67 undefined
200610 undefined

Shionogi & Co dividend payout ratio

In 2024, Shionogi & Co had a payout ratio of 19.55%. The payout ratio indicates the percentage of the company's profits that Shionogi & Co distributes as dividends.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Payout ratio
Details
Details

Payout ratio

ⓘ

What is Yearly Payout Ratio?

The yearly payout ratio for Shionogi & Co represents the proportion of earnings paid out as dividends to shareholders. It is an indicator of the company's financial health and stability, illustrating how much profit is being returned to investors versus being reinvested back into the company.

How to Interpret the Data

A lower payout ratio for Shionogi & Co could mean that the company is reinvesting more into its growth, whereas a higher ratio indicates more earnings are being distributed as dividends. Investors seeking regular income might prefer companies with a higher payout ratio, while those looking for growth may opt for companies with a lower ratio.

Using the Data for Investments

Evaluate Shionogi & Co's payout ratio in conjunction with other financial metrics and performance indicators. A sustainable payout ratio, coupled with strong financial health, can indicate a reliable dividend payout. However, a very high ratio might suggest the company is not sufficiently reinvesting in its future growth.

Shionogi & Co Payout Ratio History

DateShionogi & Co Payout ratio
2028e21.03 %
2027e20.66 %
2026e19.72 %
202522.71 %
202419.55 %
202316.89 %
202231.69 %
202110.05 %
20208.94 %
20197.67 %
20188.69 %
20179.9 %
201611.24 %
201514.14 %
201412.82 %
20137.36 %
201216.48 %
201122.31 %
201010.99 %
200922.82 %
200811.69 %
200711.01 %
200610.03 %
Eulerpool Premium

The World’s Best Investors Are On Eulerpool

Subscribe for $2
Unfortunately, there are currently no price targets and forecasts available for Shionogi & Co.

Shionogi & Co latest earnings and earnings surprises

DateEPS EstimateEPS ActualQuarterly report
9/30/202551.05 51.92  (1.71 %)2026 Q2
6/30/202541.39 46.26  (11.77 %)2026 Q1
3/31/202545.22 43.06  (-4.76 %)2025 Q4
12/31/202445.19 59.56  (31.79 %)2025 Q3
9/30/202451.83 72.05  (39.02 %)2025 Q2
6/30/202444.07 36.02  (-18.26 %)2025 Q1
3/31/202445.48 40.73  (-10.44 %)2024 Q4
12/31/2023122.55 127.24  (3.83 %)2024 Q3
9/30/2023120.12 164.03  (36.55 %)2024 Q2
6/30/2023127.28 144.62  (13.62 %)2024 Q1
1
2
3
4
5
...
7

Eulerpool ESG Scorecard© for the Shionogi & Co stock

Eulerpool World ESG Rating (EESG©)

92/ 100

🌱 Environment

99

👫 Social

99

🏛️ Governance

79

Environment

Scope 1 - Direct Emissions
41,376
Scope 2 - Indirect emissions from purchased energy
48,212
Scope 3 - Indirect emissions within the value chain
Total CO₂ emissions
89,589
CO₂ reduction strategy
Coal energy
Nuclear power
Animal experiments
Fur & Leather
Pesticides
Palm Oil
Tobacco
Genetically modified organisms
Climate concept
Sustainable forestry
Recycling regulations
Environmentally friendly packaging
Hazardous substances
Fuel consumption and efficiency
Water consumption and efficiency

Social

Percentage of female employees34.5
Percentage of women in management
Percentage of Asian employees
Share of Asian management
Percentage of Hispanic/Latino employees
Hispano/Latino Management share
Percentage of Black employees
Black Management Share
Percentage of white employees
White Management Share
Adult content
Alcohol
Weapons
Firearms
Gambling
Military contracts
Human rights concept
Privacy concept
Occupational health and safety
Catholic

Governance (Corporate Governance)

Environmental reporting
Stakeholder Engagement
Call Back Policies
Antitrust law

The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

Shionogi & Co shareholders

%
Name
Stocks
Change
Date
6.55886 % Sumitomo Life Insurance Co.55,812,00003/31/2025
5.77533 % Nomura Asset Management Co., Ltd.49,144,638-531,8007/31/2025
3.34394 % SMBC Trust Bank (Trust)28,455,00003/31/2025
2.96460 % Nippon Life Insurance Company25,227,00003/31/2025
2.91483 % The Vanguard Group, Inc.24,803,452-3,7007/31/2025
2.83269 % Nikko Asset Management Co., Ltd.24,104,559-317,9007/31/2025
2.63594 % Daiwa Asset Management Co., Ltd.22,430,31347,0997/31/2025
2.24081 % Ping An Life Insurance Company of China, Ltd19,068,00003/31/2025
2.12243 % BlackRock Fund Advisors18,060,60018,052,70012/31/2024
1.96802 % BlackRock Japan Co., Ltd.16,746,700-2,323,70012/31/2024
1
2
3
4
5
...
10

Shionogi & Co Executives and Management Board

Mr. Isao Teshirogi

(64)
Shionogi & Co Chairman of the Board, President, Chief Executive Officer, Representative Director (since 2007)
Compensation 272 M

Ms. Takuko Sawada

(69)
Shionogi & Co Vice Chairman of the Board (since 2011)
Compensation 157 M

Mr. Koji Hanasaki

Shionogi & Co Senior Executive Officer

Mr. Kazuhiro Hatanaka

(59)
Shionogi & Co Senior Executive Officer, Chief Director of Corporate Strategy

Mr. Yasuyoshi Isou

Shionogi & Co Senior Executive Officer, Chief Director of Drug Discovery Research
1
2
3
4
...
5

Shionogi & Co Supply Chain

NameRelationshipTwo-week correlationOne-month correlationThree-Month CorrelationSix-Month CorrelationOne Year CorrelationTwo-Year Correlation
Rohto Pharmaceutical Stock
Rohto Pharmaceutical
SupplierCustomer0,890,770,250,210,810,56
Shimadzu Stock
Shimadzu
SupplierCustomer0,890,410,280,560,440,55
StemRIM Stock
StemRIM
SupplierCustomer0,870,57-0,190,08-0,32-0,43
AIM ImmunoTech Stock
AIM ImmunoTech
SupplierCustomer0,810,34-0,330,13-0,64-0,61
AstraZeneca Stock
AstraZeneca
SupplierCustomer0,730,54-0,58-0,370,280,57
GlaxoSmithKline Stock
GlaxoSmithKline
SupplierCustomer0,69-0,01-0,51-0,420,480,61
Kissei Pharmaceutical Stock
Kissei Pharmaceutical
SupplierCustomer0,680,11-0,13-0,260,530,41
Sumitomo Pharma Stock
Sumitomo Pharma
SupplierCustomer0,670,680,740,37-0,67-0,22
PeptiDream Stock
PeptiDream
SupplierCustomer0,610,490,160,50-0,79-0,83
Eli Lilly Stock
Eli Lilly
SupplierCustomer0,560,70-0,51-0,160,380,67
1
2
3
4

Most common questions regarding Shionogi & Co

What values and corporate philosophy does Shionogi & Co represent?

Shionogi & Co Ltd represents values of innovation, integrity, and commitment to improving global health. The company's corporate philosophy is centered around the "Supplier of smiles" concept, aiming to contribute to the quality of life and healthcare of people worldwide. Shionogi is dedicated to delivering innovative pharmaceuticals and healthcare solutions, focusing on areas such as infectious diseases, cancer, pain management, and neuroscience. The company's emphasis on research and development, ethical practices, and strong partnerships enables Shionogi to fulfill its mission of creating a healthier future for society.

In which countries and regions is Shionogi & Co primarily present?

Shionogi & Co Ltd is primarily present in Japan, where the company is headquartered.

What significant milestones has the company Shionogi & Co achieved?

Shionogi & Co Ltd has achieved several significant milestones throughout its history. In recent years, the company successfully developed and gained approval for several groundbreaking medications, including the antiretroviral drug Delstrigo™ and the antibiotic Fetroja™. Shionogi has also established strategic partnerships with renowned pharmaceutical companies to enhance its research and development capabilities. Additionally, the company has been actively expanding its global reach, particularly in the United States and Europe, through various initiatives and collaborations. With an impressive track record of innovation and a commitment to improving global health, Shionogi & Co Ltd continues to make significant strides in the pharmaceutical industry.

What is the history and background of the company Shionogi & Co?

Shionogi & Co Ltd is a renowned pharmaceutical company based in Japan. With a rich history dating back to 1878, Shionogi has established itself as a leading player in the global healthcare industry. The company is known for its focus on research and development, aiming to discover innovative solutions to various medical challenges. Shionogi's commitment to addressing unmet medical needs has led to the development of groundbreaking drugs and treatments. Over the years, Shionogi has expanded its operations worldwide, forming strategic partnerships and collaborations to deliver high-quality pharmaceutical products to patients around the globe. Through a steadfast dedication to improving human health, Shionogi has become a respected name in the pharmaceutical field.

Who are the main competitors of Shionogi & Co in the market?

The main competitors of Shionogi & Co Ltd in the market include Takeda Pharmaceutical Co Ltd, Astellas Pharma Inc., and Daiichi Sankyo Co Ltd.

In which industries is Shionogi & Co primarily active?

Shionogi & Co Ltd is primarily active in the pharmaceutical industry.

What is the business model of Shionogi & Co?

Shionogi & Co Ltd is a pharmaceutical company that focuses on developing and marketing innovative drugs. Their business model revolves around research and development, manufacturing, and sales of pharmaceutical products. Shionogi aims to provide solutions to unmet medical needs by focusing on therapeutic areas such as infectious diseases, pain, cardiovascular disorders, and oncology. By investing in cutting-edge research, Shionogi strives to create new treatments and improve existing therapies. With a strong commitment to quality and patient-centric approach, Shionogi seeks to contribute to the well-being of society by delivering safe, effective, and high-quality pharmaceutical products.

What is the P/E ratio of Shionogi & Co 2025?

The Shionogi & Co P/E ratio is 13.22.

What is the P/S ratio of Shionogi & Co 2025?

The Shionogi & Co P/S ratio is 5.14.

What is the Quality Investing of Shionogi & Co?

The Quality Investing for Shionogi & Co is 7/10.

What is the revenue of Shionogi & Co 2025?

The Shionogi & Co revenue is 438.27 B JPY.

How high is the profit of Shionogi & Co 2025?

The Shionogi & Co profit is 170.44 B JPY.

What is the business model of Shionogi & Co

Shionogi & Co Ltd is a Japanese pharmaceutical company based in Osaka. The company was founded in 1878 and specializes in the development and marketing of innovative drugs. Shionogi combines its own research capabilities with strategic partnerships with other companies. The business model of Shionogi is based on three core divisions: 1. Pharma: This division includes the clinical development and marketing of prescription drugs. Shionogi has a wide range of medications in various therapeutic areas such as oncology, infectious diseases, diabetes, cardiovascular diseases, and neurological diseases. One of Shionogi's most well-known medications is the antibiotic Fetroja for the treatment of respiratory and urinary tract infections. 2. Consumer Healthcare: This division includes the development and marketing of over-the-counter products such as dietary supplements or cosmetics. Some of Shionogi's well-known products include Dequadin lip balm, which helps with chapped lips and cold sores, and Allelock antiallergic medication used for allergic rhinitis. 3. Research & Development: This division focuses on the research and development of innovative drugs and therapy options. Shionogi invests a considerable portion of its revenue in research and development each year. The company also collaborates closely with academic institutions and other pharmaceutical companies to accelerate the research and development of new drugs. Additionally, Shionogi has a strong focus on the Asian market. The company has subsidiaries in several Asian countries and has made significant investments in research facilities in China and Singapore in recent years. In 2020, Shionogi had a revenue of approximately 1.1 trillion yen (around 8.6 billion euros) and employed around 6,000 people in Japan and worldwide. In summary, Shionogi's business model is based on the development and marketing of innovative drugs and therapy options. The company combines its own research capabilities with strategic partnerships and operates in three core divisions: Pharma, Consumer Healthcare, and Research & Development. Shionogi also has a strong presence in the Asian market and has invested in research facilities in China and Singapore in recent years.

What is the Shionogi & Co dividend?

Shionogi & Co pays a dividend of 40 JPY distributed over payouts per year.

How often does Shionogi & Co pay dividends?

The dividend cannot currently be calculated for Shionogi & Co or the company does not pay out a dividend.

What is the Shionogi & Co ISIN?

The ISIN of Shionogi & Co is JP3347200002.

What is the Shionogi & Co WKN?

The WKN of Shionogi & Co is 855648.

What is the Shionogi & Co ticker?

The ticker of Shionogi & Co is 4507.T.

How much dividend does Shionogi & Co pay?

Over the past 12 months, Shionogi & Co paid a dividend of 56.67 JPY . This corresponds to a dividend yield of about 2.14 %. For the coming 12 months, Shionogi & Co is expected to pay a dividend of 72.2 JPY.

What is the dividend yield of Shionogi & Co?

The current dividend yield of Shionogi & Co is 2.14 %.

When does Shionogi & Co pay dividends?

Shionogi & Co pays a quarterly dividend. This is distributed in the months of April, October, April, October.

How secure is the dividend of Shionogi & Co?

Shionogi & Co paid dividends every year for the past 23 years.

What is the dividend of Shionogi & Co?

For the upcoming 12 months, dividends amounting to 72.2 JPY are expected. This corresponds to a dividend yield of 2.73 %.

In which sector is Shionogi & Co located?

Shionogi & Co is assigned to the 'Health' sector.

Wann musste ich die Aktien von Shionogi & Co kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Shionogi & Co from 12/1/2025 amounting to 33 JPY, you needed to have the stock in your portfolio before the ex-date on 9/29/2025.

When did Shionogi & Co pay the last dividend?

The last dividend was paid out on 12/1/2025.

What was the dividend of Shionogi & Co in the year 2024?

In the year 2024, Shionogi & Co distributed 50 JPY as dividends.

In which currency does Shionogi & Co pay out the dividend?

The dividends of Shionogi & Co are distributed in JPY.

All fundamentals about Shionogi & Co

Our stock analysis for Shionogi & Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Shionogi & Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.